| ¿µ¹® | heart failure | ÇÑ±Û | ½ÉÀå±â´É»ó½Ç |
|---|---|---|---|
| ¼³¸í | ¸öÀÇ Á¶Á÷À̳ª ±â°ü¿¡¼ ´ë»ç¿¡ ÇÊ¿äÇÑ ¸¸Å ÃæºÐÇÑ ¾çÀÇ Ç÷¾×À» °ø±ÞÇÒ ¼ö ¾øÀ» Á¤µµ·Î ½ÉÀå±â´ÉÀÌ ÀúÇϵǾî ÀÖ´Â »óÅÂÀÌ´Ù. ½ÉÀå±â´É»ó½ÇÀº ½É±ÙÀÌ ¼öÃàÇÒ ´É·ÂÀÌ ÀúÇϵǾúÀ» ¶§³ª ½ÉÀå¿¡ ½É¹ÚÃâÀ» Çϱâ À§ÇÑ ¾Ð·ÂÀÌ Á¤»óº¸´Ù Áõ°¡µÇ¾î Á¤»óÀÇ ½ÉÀåÀÇ ¼öÃàÀ¸·Î´Â ÃæºÐÇÑ ¾çÀÇ Ç÷¾×À» °ø±ÞÇÒ ¼ö ¾ø´Â °æ¿ì, ±×¸®°í ½ÉÀå±ÙÀ°, ½ÉÀå¿¡ °É¸®´Â ¾Ð·ÂÀº Á¤»óÀ̳ª ½ÉÀå¹Úµ¿ÀÇ ÀÌ»ó¿¡ ÀÇÇØ¼ Á¤»óÀûÀÎ ¼öÃàÀÌ ºÒ°¡´ÉÇÒ °æ¿ì¿¡ »ý±ä´Ù. |
||
| ¿µ¹® | pacemaker(of heart) | ÇÑ±Û | ½ÉÀå¹Úµ¿±â |
|---|---|---|---|
| ¼³¸í | ½ÉÀåÀÇ Àü±âÀû ÀÚ±ØÀÌ º´ÀûÀÎ »óÅ·Π¹ß»ýÇÏÁö ¾Ê°Å³ª, ȤÀº ½É½Ç·Î Àß ÀüÇØÁöÁö ¾ÊÀ» ¶§ »ç¿ëÇÑ´Ù. ÀϽÃÀû ½ÉÀå¹Úµ¿±â¿Í ¿µ±¸Àû ½ÉÀå¹Úµ¿±â°¡ ÀÖÀ¸¸ç, °¢±â ¾²ÀÌ´Â ¿ëµµ´Â º´¿¡ µû¶ó ´Ù¸£´Ù. ¿äÁò¿¡ ³ª¿À´Â ½ÉÀå ¹Úµ¿±â´Â °ÇÀüÁöÀÇ ¼ö¸íµµ ¹Ý¿µ±¸ÀûÀ̸ç, ¹Û¿¡¼ Á¶Á¤ÇÒ ¼ö ÀÖ°í, ¿îµ¿À̳ª ½ºÆ®·¹½º »óȲ¿¡ ´ëÇÑ ½ÉÀåÀÇ ºü¸¥ ¿îµ¿¿¡µµ Àß ÀûÀÀÇÒ ¼ö ÀÖµµ·Ï ¸¸µé¾îÁ® ÀÖ´Ù. |
||
| ¿µ¹® | heart disease | ÇÑ±Û | ½ÉÀ庴 |
|---|---|---|---|
| ¼³¸í | ¼øÈ¯±â Áúȯ Áß ½ÉÀåÀÇ º´. ÀϹÝÀûÀ¸·Î ½ÉÀåÇ÷°üÀ̳ª ½ÉÀåÀÇ º´µµ Æ÷ÇԵȴÙ. º´ÅÍÀÇ ºÎÀ§¿¡ ÀÇÇÑ º´¸®ÇغÎÇÐÀû ºÐ·ù¿Í º´Àο¡ ÀÇÇÑ ºÐ·ù°¡ ÀÖ´Ù. ÀüÀÚ´Â ¼ö ½Ê ³â ÀüºÎÅÍ ¾²¿©Á® ¿ÔÀ¸³ª ±Ù³â¿¡ ¿Í¼ º»ÁúÀûÀÎ ¿øÀοä¹ýÀÌ °¡´ÉÇÏ°Ô µÈ ÀÌÈÄ´Â ÈÄÀÚÀÇ ºÐ·ù°¡ ÀÇÀǰ¡ ÀÖ¾î¼ ¸¹ÀÌ ¾²ÀÌ°Ô µÇ¾ú´Ù. º´ÅÍ ºÎÀ§·Î´Â ½É³»¸·(ÆÇ¸·)-½ÉÀå±Ù-½ÉÀ帷, ±× ¹ÛÀÇ °ÍÀ» µé ¼ö ÀÖÀ¸¸ç, °¢°¢ ½É³»¸·¿°-½ÉÀåÆÇ¸·Áõ-½É±Ù¿°-½É±Ù°æ»ö-½ÉÀ帷¿°-¼±Ãµ¼º ½ÉÀ庴(½ÉÀå±âÇü) µîÀÌÆ÷ÇԵȴÙ. º´Àκ°¿¡¼´Â ½ÉÀå±âÇüÀ» ºñ·ÔÇÏ¿© ·ù¸¶Ä¡½º ½ÉÀ庴-¸Åµ¶¼º ½ÉÀ庴-°íÇ÷¾Ð¼º ½ÉÀ庴-½ÉÀ嵿¸Æ°æÈ¼º ½ÉÀ庴-Æó¼º½ÉÀå-¼¼±Õ¼º ½É³»¸·¿°-½ÉÀå½Å°æÁõ µîÀ¸·Î ³ª´©¾îÁö¸ç, ºÎÁ¤¸ÆÀ̳ª ¹æ½ÇÂ÷´Ü µîÀÇ ÀÚ±ØÀüµµ°èÀÇ Àå¾Ö¿¡ ÀÇÇÑ °Íµµ Áõ¼¼ÀÇ Çϳª·Î º¼ ¼ö ÀÖ´Ù. ½ÉÀ庴Àº ÀÚ°¢ÀûÀ¸·Î´Â ¹«Áõ¼¼ÀÎ °Í¿¡¼ºÎÅÍ ½ÉÀå±â´É»ó½Ç·Î È£Èí°ï¶õ±îÁö ÀÖ´Ù. |
||
| ¿µ¹® | septal defects of heart | ÇÑ±Û | ½ÉÀåÀÇ Áß°Ý °á¼Õ |
|---|---|---|---|
| ¼³¸í | ¼±ÃµÀûÀ¸·Î ½ÉÀå ³»ÀÇ ½É¹æ»çÀÌÁß°Ý(interatrial septum)À̳ª ½É½Ç»çÀÌÁß°Ý(interventricular septum)ÀÌ °á¼ÕµÇ¾î Ç÷·ù°¡ Á¤»óÀûÀ¸·Î È帣Áö ¾Ê´Â °æ¿ì. Á¤»óÀûÀÎ °æ¿ì Ç÷·ù´Â Á¤¸Æ¿¡¼ ¿ì½É¹æÀ¸·Î ¸ð¿© ¿ì½É½ÇÀ» °ÅÄ£µÚ Æó·Î °¡¼ »ê¼Ò¸¦ °ø±Þ¹Þ°í ´Ù½Ã ¿Þ½É¹æ, ¿Þ½É½ÇÀ» Â÷·Ê·Î °ÅÃÄ ´ëµ¿¸ÆÀ¸·Î °£´Ù. ÇÏÁö¸¸, ÀÌ °æ¿ì´Â Ç÷·ù°¡ ¾Ð·ÂÀÌ ³ôÀº ¿Þ½É¹æÀ̳ª ¿Þ½É½Ç¿¡¼ ¾Ð·ÂÀÌ ³·Àº ¿ì½É¹æÀ̳ª ¿ì½É½Ç·Î È帣°Ô µÈ´Ù. µû¶ó¼ µ¿¸ÆÇÇ¿Í Á¤¸ÆÇǰ¡ ¼¯ÀÌ°Ô µÇ°í, ȯÀڴ ȣÈí°ï¶õ, ¼ºÀå¹ßÀ°Àå¾Ö, ½ÉÀâÀ½ µîÀÌ ³ªÅ¸³ª°í, ½ÉÇÑ °æ¿ì û»öÁõÀ¸·Î ¹ßÀüÇϱ⵵ ÇÑ´Ù. Ä¡·á´Â ¼ö¼úÀûÀ¸·Î ÀÌ °á¼ÕºÎÀ§¸¦ ¸·¾Æ ÁÖ¾î¾ß ÇÑ´Ù. |
||
| AHD | acquired hepatocerebral degeneration; acute heart disease; antihyaluronidase; antihypertensive drug;... |
|---|---|
| CHD | Chediak-Higashi disease; childhood disease; chronic hemodialysis; congenital or congestive heart dis... |
| HT | Hashimoto thyroiditis; hearing test; hearing threshold; heart; heart transplantation, heart transpla... |
| DIT | deferoxamine infusion test; diet-induced thermogenesis; diiodotyrosine; drug-induced thrombocytopeni... |
| PIXE | particle-induced x-ray emission; proton-induced x-ray emission |
| alpha-chymotrypsin-induced glaucoma | Transient secondary glaucoma following the use of alpha-chymotrypsin in cataract extraction. (05 Mar 2000) |
|---|---|
| antibiotic induced enteritis | <pathology> A condition where the normal intestinal bacteria (useful for digestion) are killed by the use of an antibiotic resulting in symptoms. (27 Sep 1997) |
| antibiotic induced gastroenteritis | <pathology> A condition where the normal intestinal bacteria (useful for digestion) are killed by the use of an antibiotic resulting in symptoms. (27 Sep 1997) |
| antibody induced lysis | <haematology> The term is imprecise and should not be used since there is confusion as to which mechanism is involved, i.e. Natural killing or complement lysis. See: complement lysis, natural killer cells. (09 Feb 1998) |
| asthma, exercise-induced | Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. Inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it). (12 Dec 1998) |
| bacteriophage T7 induced DNA polymerase | <enzyme> Complex of two proteins, phage gene 5 protein and E coli thioredoxin Registry number: EC 2.7.7.- Synonym: t7 phage DNA polymerase, sequenase, t7 DNA polymerase, thermo sequenase (26 Jun 1999) |
| carbohydrate-induced hyperlipaemia | type III familial hyperlipoproteinaemia, type IV familial hyperlipoproteinaemia |
| combined fat-and carbohydrate-induced hyperlipaemia | Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance. Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia. (05 Mar 2000) |
| contact induced spreading | The response in which contact between two epithelial cells leads to a stabilised contact and the increased spreading of the cells so that the area covered is greater than that covered by the two cells in isolation. (18 Nov 1997) |
| corticosteroid-induced acne | The exacerbation of acne after corticosteroid use is a common drug reaction seen in adolescents. Lessening the dose of the corticosteroid will often diminish this effect. (27 Sep 1997) |
| corticosteroid-induced glaucoma | <ophthalmology> Glaucoma caused by a hereditary predisposition in which local instillation of eyedrops containing corticosteroid causes increased intraocular pressure. (05 Mar 2000) |
| corticosteroid-induced striae | <dermatology> High-dose glucocorticoid therapy causes atrophy of the skin and a failure of the normal regenerative process. Purple striae often develop over the individual's trunk or thighs. The colour fades when the drug is stopped, but the dermal atrophy remains. (27 Sep 1997) |
| hearing loss, noise-induced | Hearing loss from exposure to noise. The loss is often in the frequency range 4000-6000 hertz. (12 Dec 1998) |
| SA-induced protein kinase | <enzyme> 48-kD map kinase isolated from nicotiana tabacum; genbank u94192 Registry number: EC 2.7.10.- Synonym: p48 sip kinase, salicylic acid-induced protein kinase, sipk enzyme (26 Jun 1999) |
| hepatitis, chronic, drug-induced | An inflammatory disease of the liver, lasting six months or more, and caused by an adverse drug effect. The adverse effect may result from a direct toxic effect of a drug or metabolite, or an idiosyncratic response to a drug or metabolite. The clinical and histological changes can mimic viral or autoimmune hepatitis. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|